Euclidean Capital LLC Ngm Biopharmaceuticals Inc Call Options Transaction History
Euclidean Capital LLC
- $779 Million
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NGM
# of Institutions
78Shares Held
36.9MCall Options Held
1.1KPut Options Held
200-
Column Group LLC San Francisco, CA18.1MShares$017.97% of portfolio
-
Black Rock Inc. New York, NY3MShares$00.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.32MShares$00.0% of portfolio
-
Step Stone Group LP La Jolla, CA1.57MShares$00.6% of portfolio
-
Ponoi Ii Management, LLC San Francisco, CA1.3MShares$044.41% of portfolio
About NGM BIOPHARMACEUTICALS INC
- Ticker NGM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 80,365,904
- Description
- NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...